Purpose To evaluate the immunogenicity of COVID-19 vaccines in patients with diabetes
mellitus (DM) through a systematic approach. Method A comprehensive search was …

Introduction People affected by diabetes are at higher risk for complications from certain
vaccine-preventable diseases. Suboptimal vaccination coverages are reported in this …

Background: The emergence of new COVID-19 variants of concern coupled with a global
inequity in vaccine access and distribution has prompted many public health authorities to …

Patients with diabetes are more susceptible to severe acute respiratory syndrome-
associated coronavirus (SARS-CoV)-2 infection, but vaccine hesitancy is a problem in this …

OBJECTIVE Type 2 diabetes may affect the humoral immune response after vaccination, but
data concerning coronavirus disease 19 (COVID-19) vaccines are scarce. We evaluated the …

BACKGROUND Coronavirus disease 2019 (COVID-19) is one of the current global public
health threats and vaccination is the most effective tool to reduce the spread and decrease …

The mRNA-based BNT162b2 vaccine has demonstrated high efficacy against severe SARS-
CoV-2. However, data regarding immune response in people with diabetes mellitus (DM) …

Background Patients with type 2 diabetes mellitus (T2DM) have been reported to be more
susceptible to 2019 novel coronavirus (2019-nCoV) and more likely to develop severe …

In the 2 years since the COVID‐19 pandemic was officially declared, science has made
considerable strides in understanding the disease's pathophysiology, pharmacological …

Over the past two decades, diabetes mellitus (DM) has been receiving increasing attention
among autoimmune diseases. The prevalence of type 1 and type 2 diabetes has increased …